Evidence map›Paper›PMID 41736545›Full record

ArticleNucleic acids research2026

Advancing codon language modeling with synonymous codon constrained masking.

James Heuschkel, Laura Kingsley, Noah Pefaur, Andrew Nixon, Steven Cramer

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James HeuschkelBiotherapeutics Discovery Department, Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, CT 06877, United States.ORCID 0009-0003-1868-7445
Laura KingsleyBiotherapeutics Discovery Department, Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, CT 06877, United States.ORCID 0000-0002-5566-3974
Noah PefaurBiotherapeutics Discovery Department, Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, CT 06877, United States.ORCID 0009-0004-0093-5305
Andrew NixonBiotherapeutics Discovery Department, Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, CT 06877, United States.ORCID 0000-0002-6090-0583
Steven CramerDepartment of Chemical and Biological Engineering and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, United States.

Funding

Boehringer Ingelheim
6 · The paper itself

Abstract

Codon language models offer a promising framework for modeling protein-coding DNA sequences, yet current approaches often conflate codon usage with amino acid semantics, limiting their ability to capture DNA-level biology. We introduce SynCodonLM, a codon language model that enforces a biologically grounded constraint: masked codons are only predicted from synonymous options, guided by the known protein sequence. This design disentangles codon-level from protein-level semantics, enabling the model to learn nucleotide-specific patterns. The constraint is implemented by masking non-synonymous codons from the prediction space prior to softmax. Unlike existing models, which cluster codons by amino acid identity, SynCodonLM clusters by nucleotide properties, revealing structure aligned with DNA-level biology. Furthermore, SynCodonLM outperforms existing models on six of seven benchmarks sensitive to DNA-level features, including messenger RNA and protein expression. Our approach advances domain-specific representation learning and opens avenues for sequence design in synthetic biology, as well as deeper insights into diverse bioprocesses.

Indexed as

CodonCodon UsageModels, GeneticRNA, MessengerCodonRNA, Messenger

Identifiers

PMID41736545
PMCPMC12956333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.